Review Devil's tools: SARS-CoV-2 antagonists against innate immunity.

Area of Science:

• Virology and Immunology
• Infectious Diseases

Background:

• The Coronavirus pandemic of 2019 (COVID-19) is caused by SARS-CoV-2.
• SARS-CoV-2 must overcome the host's innate interferon (IFN) response to establish infection.
• The IFN response is a critical early defense mechanism against viral pathogens.

Purpose of the Study:

• To summarize the current understanding of viral factors employed by SARS-CoV-2 to suppress IFN responses.
• To identify conserved and novel IFN evasion strategies used by SARS-CoV-2.
• To provide a basis for developing IFN-based treatments against SARS-CoV-2.

Main Methods:

• Review and synthesis of existing scientific literature on SARS-CoV-2 and IFN interactions.
• Analysis of viral protein functions related to immune evasion.
• Comparison of IFN antagonism strategies between SARS-CoV and SARS-CoV-2.

Main Results:

• SARS-CoV-2 utilizes a complex array of viral proteins to antagonize the host IFN response.
• Some IFN evasion mechanisms are conserved from other coronaviruses, while others are specific to SARS-CoV-2.
• Understanding these viral countermeasures is crucial for therapeutic development.

Conclusions:

• SARS-CoV-2 has evolved sophisticated strategies to counteract the innate interferon immunity.
• Elucidating these mechanisms is essential for guiding the application of interferon therapy.
• Targeting viral IFN evasion pathways may offer a viable therapeutic strategy for COVID-19.